<DOC>
	<DOCNO>NCT02027246</DOCNO>
	<brief_summary>The aim study study effect stem cell therapy common symptom spinal cord injury patient .</brief_summary>
	<brief_title>Safety Efficacy Stem Cell Therapy Spinal Cord Injury</brief_title>
	<detailed_description>Autologous bone marrow mononuclear cell administer intrathecally standard procedure follow standard rehabilitation therapy .</detailed_description>
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Spinal Cord Injuries</mesh_term>
	<criteria>Diagnosed case type chronic Spinal cord injury Age 6 month presence acute infection Human immunodeficiency virus/ Hepatitis B Virus/ Hepatitis C Virus malignancy bleed tendency pneumonia renal failure severe liver dysfunction severe anemia [ Hemoglobin &lt; 8 ] bone marrow disorder acute medical condition respiratory infection pregnancy lactation</criteria>
	<gender>All</gender>
	<minimum_age>8 Months</minimum_age>
	<maximum_age>63 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>spinal cord injury</keyword>
	<keyword>autologous bone marrow mononuclear cell</keyword>
	<keyword>stem cell therapy</keyword>
</DOC>